Medicine and Dentistry
Glioblastoma
100%
Ganglioglioma
92%
Neoplasm
57%
Tumor Cell
25%
Radiation Therapy
23%
Cancer Stem Cell
18%
Prognostic Factor
17%
Intracranial Tumor
16%
Overall Survival
15%
Isocitrate Dehydrogenase 1
15%
Stem Cell
15%
Magnetic Resonance Imaging
14%
Cancer Therapy
14%
Disease
13%
Promoter Region
13%
Exophthalmos
11%
Junctional Adhesion Molecule A
11%
Recurrent Disease
11%
Surgery
10%
Multivariate Analysis
10%
Chemotherapy
10%
Nestin
10%
Metastatic Carcinoma
9%
Clinician
9%
Arm
8%
Optic Nerve
8%
Cell Marker
8%
Diagnosis
8%
Proton Therapy
8%
Protein Expression
7%
Macrophage
7%
Photon Therapy
7%
Malignant Neoplasm
7%
Biological Marker
7%
Microglia
7%
Image Analysis
7%
Transcription Factors
7%
Dose-Volume Histogram
7%
Neuro-Oncology
6%
Thyroid Gland
6%
Cohort Analysis
6%
Hippocampus
6%
Glioma Cell
5%
Phosphotransferase
5%
Tumor Recurrence
5%
Bladder Cancer
5%
Tumor Treating Fields
5%
Randomized Controlled Trial
5%
Kidney Tumour
5%
Methyltransferase
5%
Biochemistry, Genetics and Molecular Biology
Multivariate Analysis
27%
Cancer Stem Cell
25%
Isocitrate Dehydrogenase
20%
Overall Survival
18%
CD133
17%
Methylation
16%
Promoter Region
13%
Immunofluorescence
11%
RNA-binding Protein
8%
Protein Expression
7%
Stem Cell Marker
7%
Transcription Factors
7%
Macrophage
6%
Microglia
6%
DNA Methyltransferase
6%
Cell Membrane
5%
Phosphotransferase
5%
Kinase
5%
Biomarker Study
5%
Gene Expression
5%
Digital Pathology
5%
Tumor Volume
5%
Tyrosine Kinase Receptor
5%
Galectin
5%
PD-L1
5%
EGR1
5%
Genetic Divergence
5%
Immune Checkpoints
5%
Methyltransferase
5%
Next Generation Sequencing
5%
Bevacizumab
5%
Retrospective Study
5%
Glycosylase
5%
Vitamin C
5%
Flow Cytometry
5%
Gadolinium
5%
Cell Adhesion Proteins
5%
Tumor-Associated Macrophage
5%
Progression Free Survival
5%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
43%
Neoplasm
41%
Malignant Neoplasm
20%
Overall Survival
19%
Nestin
8%
Isocitrate Dehydrogenase 1
7%
Recurrent Disease
7%
Cell Marker
6%
Methylated DNA Protein Cysteine Methyltransferase
6%
DNA Methyltransferase
5%
Meningioma
5%
Bladder Cancer
5%
Randomized Controlled Trial
5%
Cross-Sectional Study
5%
Glioma
5%
Methyltransferase
5%
Bevacizumab
5%
Irinotecan
5%
Exophthalmos
5%
Temozolomide
5%
Chemotherapy
5%
